AmpliPhi Biosciences (Formerly known as Targeted Genetics)
4870 Sadler Road
Suite 300
Glen Allen
Virginia
23060
United States
Tel: 804-205-5069
Fax: 206-223-0288
Website: http://www.ampliphibio.com/
281 articles about AmpliPhi Biosciences (Formerly known as Targeted Genetics)
-
AmpliPhi Bio’ Bacteriophage Cocktail Shown To Prevent C. difficile Biofilm Formation And Reduce Colonization
9/12/2016
-
AmpliPhi Bio Reports Second Quarter 2016 Financial Results And Provides Corporate Update
8/16/2016
-
AmpliPhi Bio Confirms Clinical Trial Progress And Announces Upcoming Conference Call To Provide Corporate Update And Discuss Second Quarter 2016 Financial Results On August 15, 2016
8/9/2016
-
AmpliPhi Bio Granted Japanese Patent Covering The Use Of Phage Therapy To Resensitize Pseudomonas Aeruginosa Infections To Antibiotics
8/4/2016
-
AmpliPhi Bio Completes Enrollment Of Its Investigational Phage Therapy Trial Targeting Staphylococcus Aureus
8/3/2016
-
AmpliPhi Bio To Be Granted European Patent Covering The Use Of Phage Therapy To Resensitize Bacterial Infections To Antibiotics
6/2/2016
-
BIO2016: AmpliPhi Bio’s CEO To Discuss Novel Approaches To Fighting Drug-Resistant Pathogens In Panel At BIO International
5/31/2016
-
AmpliPhi Bio Announces Start Of First Phage Therapy Trial In U.S. Under IND
5/24/2016
-
AmpliPhi Bio Reports First Quarter 2016 Financial Results And Provides Corporate Update
5/13/2016
-
AmpliPhi Bio Provides Update On Phase I Trial: Phage Therapy Well Tolerated In First Cohort
4/20/2016
-
AmpliPhi Bio Abandons Deal with Intrexon
4/14/2016
-
AmpliPhi Biosciences Corporation Presents Data Showing Bacteriophage Product Candidate Kills Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients
4/13/2016
-
AmpliPhi Biosciences Corporation Announces Conversion Of all Series B Redeemable Preferred Stock Into Common Stock
4/11/2016
-
AmpliPhi Biosciences Corporation Reports Full-Year 2015 Financial Results
3/31/2016
-
AmpliPhi Biosciences Corporation To Host Full-Year 2015 Financial Results Conference Call And Webcast On March 30, 2016
3/29/2016
-
AmpliPhi Biosciences Corporation CEO To Present At 28th Annual ROTH Conference
3/8/2016
-
AmpliPhi Biosciences Corporation Announces Award Of Federal Research Grant From Australia To Its Collaboration Partner, Westmead Institute
2/9/2016
-
AmpliPhi Biosciences Corporation Announces Dosing Of First Patient In Phase I Clinical Trial Of AB-SA01
1/20/2016
-
AmpliPhi Biosciences Corporation Announces Appointment Of Steve R. Martin As Chief Financial Officer
1/19/2016
-
AmpliPhi Biosciences Corporation Acquires Key Bacteriophage Assets From UK-based Novolytics
1/8/2016